A combination of retinoic acid and proteasome inhibitors for the treatment of leukemias is potentially dangerous [1]

C. Wojcik, I. Mlynarczuk, G. Hoser, J. Kawiak, T. Stoklosa, J. Golab, S. Wilk

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'A combination of retinoic acid and proteasome inhibitors for the treatment of leukemias is potentially dangerous [1]'. Together they form a unique fingerprint.